ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Blueprint Medicines (UK) Ltd

Blueprint Medicines (UK) Ltd is an active company incorporated on 3 July 2019 with the registered office located in London, Greater London. Blueprint Medicines (UK) Ltd was registered 6 years ago.
Status
Active
Active since incorporation
Company No
12084232
Private limited company
Age
6 years
Incorporated 3 July 2019
Size
Small
Turnover is under £15M
Balance sheet is under £7.5M
Confirmation
Submitted
Dated 29 June 2025 (4 months ago)
Next confirmation dated 29 June 2026
Due by 13 July 2026 (8 months remaining)
Last change occurred 5 years ago
Accounts
Submitted
For period 1 Jan31 Dec 2024 (1 year)
Accounts type is Small
Next accounts for period 31 December 2025
Due by 30 September 2026 (10 months remaining)
Address
55 Baker Street
London
W1U 7EU
United Kingdom
Address changed on 14 Mar 2025 (8 months ago)
Previous address was 55 Baker Street London United Kingdom W1U 8EW England
Telephone
Unreported
Email
Unreported
Website
Unreported
People
Officers
4
Shareholders
1
Controllers (PSC)
1
Director • German • Lives in Switzerland • Born in Mar 1970
Director • French • Lives in Switzerland • Born in Oct 1981
Director • Business Executive • American • Lives in United States • Born in Mar 1972
Director • British • Lives in Wales • Born in May 1982
Sanofi
PSC
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
T&K Jones Holdings Ltd
Timothy Andrew Jones is a mutual person.
Active
Ta Jones Holdings Ltd
Timothy Andrew Jones is a mutual person.
Active
Financials
Net Assets, Total Assets & Total Liabilities (2020–2024)
Period Ended
31 Dec 2024
For period 31 Dec31 Dec 2024
Traded for 12 months
Cash in Bank
£412.05K
Increased by £385.51K (+1452%)
Turnover
£3.01M
Increased by £634.87K (+27%)
Employees
4
Same as previous period
Total Assets
£1.44M
Increased by £550.8K (+62%)
Total Liabilities
-£589.05K
Decreased by £3.23K (-1%)
Net Assets
£846.25K
Increased by £554.03K (+190%)
Debt Ratio (%)
41%
Decreased by 25.92% (-39%)
Latest Activity
Georg Meyer Resigned
9 Days Ago on 31 Oct 2025
Michael David Landsittel Resigned
9 Days Ago on 31 Oct 2025
Small Accounts Submitted
1 Month Ago on 6 Oct 2025
Sanofi (PSC) Appointed
3 Months Ago on 18 Jul 2025
Blueprint Medicines Corporation (PSC) Resigned
3 Months Ago on 18 Jul 2025
Confirmation Submitted
4 Months Ago on 30 Jun 2025
Registered Address Changed
8 Months Ago on 14 Mar 2025
Mr Timothy Andrew Jones Details Changed
10 Months Ago on 1 Jan 2025
Small Accounts Submitted
1 Year Ago on 12 Oct 2024
Inspection Address Changed
1 Year 4 Months Ago on 10 Jul 2024
Get Credit Report
Discover Blueprint Medicines (UK) Ltd's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Termination of appointment of Georg Meyer as a director on 31 October 2025
Submitted on 31 Oct 2025
Termination of appointment of Michael David Landsittel as a director on 31 October 2025
Submitted on 31 Oct 2025
Accounts for a small company made up to 31 December 2024
Submitted on 6 Oct 2025
Cessation of Blueprint Medicines Corporation as a person with significant control on 18 July 2025
Submitted on 29 Sep 2025
Notification of Sanofi as a person with significant control on 18 July 2025
Submitted on 29 Sep 2025
Confirmation statement made on 29 June 2025 with no updates
Submitted on 30 Jun 2025
Director's details changed for Mr Timothy Andrew Jones on 1 January 2025
Submitted on 30 Jun 2025
Registered office address changed from 55 Baker Street London United Kingdom W1U 8EW England to 55 Baker Street London W1U 7EU on 14 March 2025
Submitted on 14 Mar 2025
Accounts for a small company made up to 31 December 2023
Submitted on 12 Oct 2024
Register inspection address has been changed from R+ Bdo Blagrave Street Reading United Kingdom RG1 1AZ England to Bdo Birmingham - Snowhill Two Snowhill 7th Floor Birmingham B4 6GA
Submitted on 10 Jul 2024
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year